Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Amortization - GoodwillEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsReceivables RefundsShares IssuedShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Bruker (BRKRP) EBIAT (2016 - 2025)

Historic EBIAT for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to -$59.6 million.

  • Bruker's EBIAT fell 24572.13% to -$59.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.2 million, marking a year-over-year decrease of 10629.3%. This contributed to the annual value of $115.3 million for FY2024, which is 7309.22% down from last year.
  • Latest data reveals that Bruker reported EBIAT of -$59.6 million as of Q3 2025, which was down 24572.13% from $7.6 million recorded in Q2 2025.
  • In the past 5 years, Bruker's EBIAT ranged from a high of $204.6 million in Q4 2023 and a low of -$59.6 million during Q3 2025
  • Moreover, its 5-year median value for EBIAT was $57.8 million (2021), whereas its average is $57.3 million.
  • As far as peak fluctuations go, Bruker's EBIAT skyrocketed by 44528.3% in 2021, and later crashed by 24572.13% in 2025.
  • Bruker's EBIAT (Quarter) stood at $76.0 million in 2021, then grew by 29.34% to $98.3 million in 2022, then soared by 108.14% to $204.6 million in 2023, then crashed by 92.47% to $15.4 million in 2024, then crashed by 487.01% to -$59.6 million in 2025.
  • Its EBIAT was -$59.6 million in Q3 2025, compared to $7.6 million in Q2 2025 and $17.4 million in Q1 2025.